Political parties have pulled up their socks to submit forms for enrolling left over voters in the Electoral rolls in Uttar ...

Ranveer Singh’s ‘Dhurandhar’ beats Aamir Khan’s ‘PK’ to become the 10th biggest Indian hit in North America ...

Living with HD is challenging enough, but depression and anxiety, two of the most common psychiatric symptoms in HD, can make everything exponentially harder. Imagine trying to navigate your daily ...

Enrollment at the nation's colleges and universities is up for the third straight year, according to a preliminary report. In a difficult year marked by several federal policy challenges and financial ...

HUNTINGTON’S disease is progressive and incurable, so modifiable factors that influence symptom onset and progression are clinically relevant. Using Periodic Dataset 4 from Enroll-HD, investigators ...

Recent findings of a drug trial tested an effective gene therapy that slows down the progression of Huntington’s disease by 75% compared to not receiving the therapy. Huntington’s disease occurs ...

Dutch biotech uniQure (Nasdaq: QURE) has reported pivotal Phase I/II results showing its experimental gene therapy AMT-130 slowed Huntington’s disease progression by 75% at three years in patients ...

The last time I wrote an article on uniQure N.V. (QURE), it was in a Seeking Alpha article entitled "uniQure: AMT-130 For HD Progresses Forward With Q2 2025 FDA Meeting." With respect to that article, ...

uniQure reported positive topline data from the pivotal Phase I/II study of AMT-130 for the treatment of Huntington’s disease. The study met its prespecified primary endpoint, with high-dose AMT-130 ...

UniQure has announced positive top-line results from its Phase I/II trial of AMT-130, a one-time gene therapy being tested in people with Huntington’s disease (HD). Topline data is a summary of the ...

A global clinical trial for a new Huntington’s disease treatment has posted positive results today, announced by trial sponsor uniQure and UCL scientists. The researchers found that patients receiving ...

This important manuscript presents a novel application of the SANDI (Soma and Neurite Density Imaging) model to study microstructural alterations in the basal ganglia of individuals with Huntington's ...